Did you know that three of the major global health product development partnerships in the U.S. are headquartered in New York? Or that New York City has the largest bioscience workforce and second largest life sciences workforce of any U.S. city, employing 80,000 people?
On April 9, Research!America is hosting a forum in New York City to discuss how global health R&D in New York is fueling innovation and saving lives worldwide. Mary Woolley, president and CEO of Research!America, and Rep. Nita Lowey (D-NY) will make opening remarks. Influential commentator Laurie Garrett will moderate an expert panel that will showcase the contributions of innovative global health partnerships to the state's economy. Panelists include Jack DeHovitz, MD, MPH, director, SUNY Downstate AIDS International Training and Research Program; Margaret McGlynn, president and CEO, International AIDS Vaccine Initiative; Mel Spigelman, MD, president and CEO, Global Alliance for TB Drug Development; and Pol Vandenbroucke, MD, vice president of development, emerging markets, Pfizer.
Research!America will also release a fact sheet detailing the economic impact of global health R&D in New York and the results of a state public opinion poll on the value of global health research. Please visit Global Health R&D in New York for more information.